Atricure Inc., Max1 Isolator Transpolar Pen. Model A000163. Used to ablate cardiac tissues dur...
FDA Device Recall #Z-0912-2013 — Class II — January 14, 2013
Recall Summary
| Recall Number | Z-0912-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 14, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Atricure Inc |
| Location | West Chester, OH |
| Product Type | Devices |
| Quantity | 5 devices |
Product Description
Atricure Inc., Max1 Isolator Transpolar Pen. Model A000163. Used to ablate cardiac tissues during cardiac surgery using radiofrequency energy when connected to the AtriCure Ablation and Sensing Unit or for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to a temporary external cardiac pacemaker or recording device.
Reason for Recall
Products from lot no. 41865 may have been sent out with Incorrect Instructions for Use (IFU) labeling.
Distribution Pattern
Nationwide Distribution including the states of MD, PA and TX.
Lot / Code Information
Model Number(s): MAX1 A000163, Lot Number 41865
Other Recalls from Atricure Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0895-2015 | Class II | Cryogenic probe for cardiac ablation surgery, p... | Nov 21, 2014 |
| Z-1209-2014 | Class II | Reusable Clip Applier Manufactured by AtriCure,... | Jan 23, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.